|
Volumn 5, Issue , 2006, Pages
|
A case study evaluating the use of clozapine in depression with psychotic features
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMITRIPTYLINE;
ANTIDEPRESSANT AGENT;
ATYPICAL ANTIPSYCHOTIC AGENT;
CHLORPROMAZINE;
CLOZAPINE;
DEXAMETHASONE;
HALOPERIDOL;
LITHIUM CARBONATE;
LORAZEPAM;
MIRTAZAPINE;
MOOD STABILIZER;
NEUROLEPTIC AGENT;
OLANZAPINE;
ADULT;
ARTICLE;
BIPOLAR DISORDER;
CASE REPORT;
CASE STUDY;
CLINICAL FEATURE;
DEPRESSIVE PSYCHOSIS;
DIFFERENTIAL DIAGNOSIS;
DISEASE DURATION;
DISEASE SEVERITY;
DRUG DOSE INCREASE;
DRUG DOSE REDUCTION;
DRUG DOSE TITRATION;
DRUG WITHDRAWAL;
ELECTROCONVULSIVE THERAPY;
EVIDENCE BASED MEDICINE;
FAMILY HISTORY;
FEMALE;
FUNCTIONAL STATUS;
HOSPITAL ADMISSION;
HOSPITAL DISCHARGE;
HOSPITAL PATIENT;
HUMAN;
MEDICAL RESEARCH;
MENTAL DISEASE;
MOOD DISORDER;
PATIENT MONITORING;
POSTTRAUMATIC STRESS DISORDER;
SCHIZOAFFECTIVE PSYCHOSIS;
SYMPTOMATOLOGY;
TREATMENT OUTCOME;
UNSPECIFIED SIDE EFFECT;
|
EID: 33845672653
PISSN: None
EISSN: 1744859X
Source Type: Journal
DOI: 10.1186/1744-859X-5-20 Document Type: Article |
Times cited : (8)
|
References (9)
|